NCT03853538

A Study to Gain Information How Well Dexpanthenol Dermal Spray Helps the Face Skin to Recover After Cosmetic Lasering

Evaluation of the Safety and Efficacy of the Product Bepantol® Derma Spray After the Dermatological Procedure in the Face - 21 Days of Follow-up.

• Status: Completed
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 33 (actual)
• Sponsor: Bayer · Industry
• Sex: Female
• Age: 30 Years – 60 Years
• Healthy volunteers: Accepted

Summary

In this study, researchers want to learn more about the effect of dexpanthenol dermal spray on skin recovery and reduction of skin redness after a dermatological procedure (non-ablative laser) on the face for treatment of fine wrinkles, scars, open pores and change of pigmentation. After the dermatological procedure, participants will return within 3 weeks for 4 visits to the study center to investigate the skin conditions such redness, irritation, softness and possible side effects. In addition, study participants will be asked about their general acceptance of dexpanthenol dermal spray.

Detailed description

The primary objective is to evaluate the efficacy of the test product to aid skin recovery and reduction of erythema after non-ablative lasering on the face. Secondary objectives comprise clinical efficacy with respect to skin hydration, softness, vitality, appearance etc. and skin recovery, consumer judgement of product performance and acceptability, and safety.

Conditions

• Erythema
• Skin Recovery

Interventions

Type	Name	Description
DRUG	BAY207543 (Bepanthol, Bepantol® Derma Spray)	Product is applied to one hemiface.
OTHER	Semisolid vaseline	Product is applied to one hemiface.

Timeline

• Start date: 2019-01-28
• Primary completion: 2019-03-06
• Completion: 2019-03-06
• First posted: 2019-02-25
• Last updated: 2020-03-09

Locations

1 site across 1 country: Brazil